Heart failure is a common, complex, and costly condition accompanied by a high degree of symptom burden. The concept of heart failure symptom burden has been used and measured inconsistently in research. To develop effective symptom management and palliation strategies, a clear conceptual understanding is needed. Rodgers' evolutionary method of concept analysis was used to identify articles in CINAHL, Embase, Scopus, and PubMed focused on chronic heart failure. Analysis of 20 articles revealed key attributes (subjectivity, negative impact on daily life and/or overall functioning, synergistic symptom associations, and symptom exacerbation), related terms (symptom distress and symptom experience), a surrogate term (heart failure burden), antecedents (heart failure classification or stage), and consequences (increased morbidity/mortality, decreased functioning, increased symptom prevalence/ severity, decreased quality of life, and recurrent hospital admissions). No gold standard for measurement was identified. Research is needed to validate heart failure symptom burden measurement strategies across populations.
An estimated 6.5 million adults above the age of 20 are diagnosed with heart failure, and prevalence is expected to reach 8.5 million by 2030 (Benjamin et al., 2017) . As a result of hospital readmission rates and medical complexity, heart failure is one of the costliest diagnoses in the United States; current projections estimate that by 2030, heart failure total medical costs will reach $53 million annually (Heidenreich et al., 2013) . Hospital admissions-and, therefore, their associated costs-are often driven by individuals seeking care for symptom exacerbations of pain, dyspnea, depression, anxiety, fatigue, and so forth (Fida & Piña, 2012) . High symptom burden can also cause significant patient suffering. Therapies and medications help medically optimize symptomatic patients, but therapies are not always completely effective. Palliative care, defined by the World Health Organization (2010) as an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual, has been recommended by cardiovascular professional organizations and remains an understudied strategy to alleviate suffering and symptom burden in patients with advanced disease (Yancy et al., 2017; Yancy et al., 2013) . As a recommended standard for care, it is important to consider both concurrent cardiology and palliative care when treating individual symptoms and symptom burden holistically.
What Is Symptom Burden in Heart Failure?
The term "symptom experience" has been extensively studied primarily in oncology (Dodd et al., 2001) . In previous work, Dodd et al. (2001) identified three aspects of symptom experience including symptom perception, evaluation, and response. Later work including a previous concept analysis sought to identify and analyze the similar term of "symptom burden" across disease modalities-again with emphasis in oncology-and defined symptom burden as "the subjective, quantifiable prevalence, frequency, and severity of symptoms placing a physiologic burden on patients and producing multiple negative, physical, and emotional patient responses" (Gapstur, 2007, p. 677) . More recent research has focused on further defining what symptom burden consists of in other disease modalities and life contexts (Corwin et al., 2014) . Although symptom burden, symptom experience, and symptom distress have all been examined in general populations with an emphasis on the oncology population (Armstrong, 2003; Gapstur, 2007; Stapleton, Holden, Epstein, & Wilkie, 2016) , symptom burden is more relevant and descriptive when anchored in the primary diagnosis, and clinical specialists may be more concerned with those symptoms specific to the diseases that affect populations they work with. Because heart failure is characterized by an unpredictable disease trajectory-more so than in the cancer population-it would be inaccurate to generalize the oncology patient's experience to that of the heart failure population (Yancy et al., 2017) . Even within a single diagnosis, symptom burden can occur along a continuum, with differing disease severity and patient stability. For example, patients with acute decompensated heart failure may have a more severe burden when compared with patients who are living with chronic heart failure and functionally independent (Lee, Moser, Pelter, Nesbitt, & Dracup, 2017) .
Clinical researchers often measure symptom burden; however, there is inconsistency among clinicians and researchers about the conceptual and operational understanding of this concept. Existing instruments may not include all symptoms that can decrease a patient's health-related quality of life, especially when instruments are developed and targeted for specific populations (Richardson & Jones, 2009) . For example, non-heart failure-specific instruments such as the Edmonton Symptom Assessment Scale or symptom checklists have been used to operationalize symptom burden in heart failure, but do not consist of more cardiovascular centric symptoms such as chest pain (Richardson & Jones, 2009) . Instruments operationalizing symptom burden specifically in heart failure populations such as the Memorial Symptom Assessment Scale-Heart Failure (Zambroski et al., 2004) or healthrelated quality of life instruments such as the Minnesota Living With Heart Failure Questionnaire (Rector, Kubo, & Cohn, 1993) include many symptoms specific to heart failure, but may miss symptoms from comorbidities that affect heart failure burden.
The lack of clarity in how the concept of heart failure symptom burden is defined and measured demonstrates that providers need a better understanding of the breadth of the concept including its application to symptoms associated with heart failure etiology and pathology. A consistent definition would aide in the operationalization and measurement of heart failure symptom burden and lead to more effective, targeted symptom management strategies. Furthermore, in conditions with unpredictable trajectories such as heart failure, where symptomatic patients are recruited (from the acute, inpatient or the more stable outpatient setting) is important when analyzing the significance of symptom burden measurement results.
Purpose
The purpose of this concept analysis is to explore the concept of symptom burden to understand how the term has been used and measured in relation to patients with chronic heart failure. As the understanding of "symptom experience" has grown and become more specific (e.g., symptom burden, symptom distress) and treatments have changed or adapted with patients living longer outside of the hospital with the option of palliative services in advanced cardiovascular disease, the concept of symptom burden in heart failure has had the opportunity to change and expand as well (Ezekowitz, Kaul, Bakal, Quan, & McAlister, 2011; Kavalieratos et al., 2017) . Research has identified and focused on the measurable components of symptom burden (prevalence, severity, frequency; Dodd et al., 2001 ), but a lack of inclusion of conceptual development in the concept can be problematic as symptoms are complicated with multiple factors affecting them. Further conceptual and operational precision may be key to understanding an intervention's effectiveness.
Method
Rodgers' evolutionary method of concept analysis, consisting of six defined steps-(a) identifying a concept of importance and its associated terms, (b) selecting a setting or sample from which to collect data, (c) collecting the data, (d) analyzing the data (inclusive of identifying key defining attributes, related terms, antecedents, and consequences relating to the concept), (e) identifying a concept exemplar, and (f) identifying a hypothesis and/or implications for development of the concept going forward (Wills & McEwen, 2014) -was used for this review. Attributes, consequences, antecedents, and related terms were determined by investigator-determined commonalities in selected articles with expert review from coauthors.
Search Method
Because the original definition of a concept may become hazy over time, multiple similar yet unequivocal terms can emerge that can be measured differently (Rodgers, 2000) . Identified associated terms that might be pertinent to the concept of symptom burden include symptom distress and symptom experience. Although these terms might not be completely synonymous, there is some overlap in the phenomena and associated characteristics they are trying to describe (Wills & McEwen, 2014) . Each of the terms includes attributes of the effects and associations between the patient and their symptoms or the symptom effects.
Four databases including CINAHL, Embase, Scopus, and PubMed were searched by the primary author using the key terms "Heart Failure" AND ("Symptom Burden" OR "Symptom Experience" OR "Symptom Distress") AND ("Outpatient OR Ambulatory OR Chronic") . The evolution of the concept and its context are of great importance as they shape the definition of the concept and how it is utilized (Rodgers, 2000) , meaning symptom burden could greatly differ if it was analyzed in the context of the hospital or community setting. Articles were included if they were written in English, research studies, or published before 2018.
Screening and Eligibility
A total of 419 articles were identified (CINAHL = 76, Embase = 137, Scopus = 112, and PubMed = 94) and screened for eligibility by the first author. After deleting duplicates (n = 253), 166 article abstracts were screened to verify relevance, resulting in the removal of 88 articles, which did not address either symptom burden or a heart failure patient's experience of multiple symptoms. Of the remaining 78 papers, 49 were excluded as they were deemed irrelevant to the chosen population. For example, the excluded articles involved works that had a sole focus on atrial fibrillation, caregiver burden, inpatient participants, or included multiple disease-specific populations as a single group. An additional nine nonempirical research studies from the remaining 29 were excluded. Figure 1 depicts the article selection process using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis diagram. A total of 20 articles were included in the final analysis (15 observational studies, three randomized controlled trials, and two qualitative studies).
Results

Attributes
There were four identified attributes of symptom burden including the symptom subjectivity, a negative impact on daily life and/or overall functioning, synergistic symptom associations, and symptom exacerbations. Table 1 compares a previous concept analysis of the term symptom burden and the associated attributes in comparison with those identified in this concept analysis.
Subjective experience. Symptoms can be reported from perspectives other than the patients. For example, in one study, retrospective chart reviews were used to gain insight of the symptom prevalence experienced by the heart failure patients at a specific outpatient palliative care clinic embedded in a cardiology clinic (Gandesbery, Dobbie, & Gorodeski, 2018) . However, heart failure symptom burden was measured most often through patient selfreported measures and interpretation was dependent on the patient's perception (Bekelman et al., 2007; Bekelman et al., 2009; Bekelman et al., 2018; Blinderman et al., 2008; Bondmass, 2007; Evangelista et al., 2012; Flint et al., 2017; Gerhardt, Weidner, Grassmann, & Spaderna, 2014; Gusick, 2008; Janssen, Spruit, Uszko-Lencer, Schols, & Wouters, 2011; Moser, Doering, & Chung, 2005; Østergaard et al., 2018; Zambroski, Moser, Bhat, & Ziegler, 2005) . Given symptom burden's subjective nature, self-report is highly appropriate. When a patient reports multiple symptoms, the patient may not consider a specific symptom as "burdensome" depending on how the symptom affects his or her function, for example, some patients have reported difficulty sleeping as their most burdensome symptom-even though the clinician may view shortness of breath and fatigue as the most common distressing symptoms (Blinderman et al., 2008) . A patient may not perceive a symptom as burdensome if it does not directly affect his or her ability to function in his or her normal day-to-day activities. Identifying and grading a symptom on severity can become increasingly difficult to assess, particularly as prognosis and health status decline in advanced heart failure patients. This difficulty is exacerbated with comorbid conditions and age-related declines in activities of daily living (Flint et al., 2017) . Table 2 describes the empirical instruments used to measure symptom burden (qualitative studies not included). Of the 18 studies, eight used a single instrument to quantify symptom burden (Bondmass, 2007; Brännström & Boman, 2014; Evangelista, Liao, Motie, De Michelis, & Lombardo, 2014; Gandesbery et al., 2018; Graven, Martorella, Gordon, Keltner, & Higgins, 2017; Østergaard et al., 2018; Overbaugh & Parshall, 2016; Zambroski et al., 2005) , few of which included psychological symptoms such as depression. Ten studies used multiple instruments, usually a general physical symptom burden instrument combined with other(s) to quantify psychological symptoms such as anxiety and depression (Bekelman et al., 2018; Bekelman et al., 2009; Blinderman et al., 2008; Evangelista et al., 2012; Flint et al., 2017;  Gerhardt et al., 2014; Gusick, 2008; Janssen et al., 2011; Moser et al., 2005) . The 18 studies used nine different or modified instruments to measure symptom burden, four of which were heart failure specific (e.g., Dyspnea/Fatigue Index, Memorial Symptom Assessment Scale-Heart Failure, Memorial Symptom Assessment Scale-Short Form, Heart Failure Symptom Distress Scale, 13-Item Visual Analog Scale, Edmonton Symptom Assessment Scale, Heart Failure Symptom Survey, Kansas City Cardiomyopathy Questionnaire, General Symptom Distress Scale). An additional 10 measures of psychological symptoms were included, yielding a total of 19 empirical instruments. The prevalence, frequency, and severity of symptoms perceived and experienced by heart failure patients were common aspects measured in these studies.
Synergistic symptom associations.
All studies identified multiple symptoms comprising heart failure symptom burden. Investigators noted that heart failure patients can experience multiple symptoms in one period of time, which together can contribute to symptom burden (Bekelman et al., 2007; Gusick, 2008; Lee, Vincent, & Finnegan, 2017; Zambroski et al., 2005) . Due to the large number of comorbidities in heart failure patients, symptoms can be additive or even exponential, contributing to overall burden and decreased health status and quality of life (Bekelman et al., 2007; Blinderman et al., 2008; Flint et al., 2017; Lee, Vincent, & Finnegan, 2017; Zambroski et al., 2005) . Although psychological and cognitive symptoms are often included in the definition of symptom burden, most studies measured and defined these symptoms as separate from their overall symptom burden ( Table 2) .
Exacerbations of symptoms. An important consideration of investigators was the unpredictable disease trajectory and waxing and waning of symptom exacerbations that characterize heart failure (Gusick, 2008; Lem & Schwartz, 2014; Moser et al., 2005) . Symptom number and severity may be transient and/or recurring; for example, dyspnea exacerbations were often associated with acute heart failure decompensation and with multiple treatment options to address the underlying mechanism causing the symptom (Evangelista et al., 2014; Evangelista et al., 2012; Gusick, 2008; Lem & Schwartz, 2014 ). An individual with chronic heart failure may experience periods of quiescence; such periods can change quickly with fluctuating disease status. In addition, symptom exacerbations are associated with hospitalizations, and many studies include hospitalizations as an outcome due to their significant financial impact (Bekelman et al., 2018; Bondmass, 2007; Brännström & Boman, 2014; Zambroski et al., 2005) . The number of exacerbations and length of hospital stays may have a considerable impact on heart failure patients' quality of life, especially when almost 50% of heart failure patients die within five years of diagnosis (Benjamin et al., 2017) . Recording symptom trajectories along with their ebbs and flows are important for anticipating and managing symptoms associated with the unpredictable trajectory of heart failure symptoms, and this characteristic is part of what differentiates symptom burden in heart failure from cancer.
Negative impact on daily life and/or overall functioning. For the patient's experience to be classified as a burden, it must have a negative impact on the patient's life. First, the patient must have an identified symptom, whether it is physical, psychological, or other. The symptom must have some quantifiable negative impact or a negative symptom experience that affects the individual's life, quality of life, or an aspect of the individual's overall functioning (Evangelista et al., 2012; Flint et al., 2017; Gerhardt et al., 2014) . The perceived negative effect may be the expenditure of more energy to participate in activities the individual once enjoyed or more observable impacts such as the effect of dyspnea on an individual's ability to engage in physical activity. Most studies focused on patient perceptions of the negative effects on overall functioning and daily life, measured by patient-reported outcomes, rather than the health care providers' or caregivers' perception of the symptoms (Bekelman et al., 2018; Bekelman et al., 2007; Bekelman et al., 2009; Bennett, Cordes, Westmoreland, Castro, & Donnelly, 2000; Blinderman et al., 2008; Bondmass, 2007; Evangelista et al., 2012; Flint et al., 2017; Gerhardt et al., 2014; Gusick, 2008; Janssen et al., 2011; Moser et al., 2005; Østergaard et al., 2018; Zambroski et al., 2005) .
Characteristics of the Concept
Surrogate and related terms. Heart failure burden was identified as a surrogate term synonymous with symptom burden in heart failure and encompasses the unique symptom and disease burden associated with heart failure (Lem & Schwartz, 2014) . However, it can also encompass other non-symptomspecific aspects of burden. Related terms identified in the literature include symptom distress (Blinderman et al., 2008; Bondmass, 2007; Gerhardt et al., 2014) and symptom experience (Bekelman et al., 2018; Bekelman et al., 2007; Bekelman et al., 2009; Brännström & Boman, 2014; Evangelista et al., 2014; Evangelista et al., 2012; Flint et al., 2017; Gandesbery et al., 2018; Gusick, 2008; Lem & Schwartz, 2014; Moser et al., 2005; Østergaard et al., 2018; Overbaugh & Parshall, 2016; Zambroski et al., 2005) . Although these terms are often used synonymously with symptom burden in heart failure, they are not always used as surrogate terms. For example, although symptom burden and distress both refer to the negative symptom experience in heart failure, distress has a more immediate, negative connotation-possibly more closely associated with severe disease or symptom burden (Evangelista et al., 2014; Janssen et al., 2011) . In addition, whereas both symptom experience and symptom burden refer to the patient's perception of living with heart failure symptoms, symptom burden carries the negative connotation that was not the focus of previous work done when the term of symptom experience was being developed as an aspect of symptom management (Dodd et al., 2001) . Symptom experience may place more focus on patient perception of living with a symptom in general, whereas symptom burden has more emphasis on the burden or negative effect placed on the patient by the symptoms. Even with a possible distinction, several studies used multiple terms including symptom burden and symptom distress interchangeably (Blinderman et al., 2008; Gerhardt et al., 2014) .
Antecedents. Antecedents of symptom burden in heart failure included a heart failure diagnosis and classification or staging of disease severity. The extent and severity of heart failure and its symptoms are commonly classified after diagnosis using the New York Heart Association classifications (I-IV) and American Heart Association stages (A-D; Dolgin, Fox, Gorlin, & Levin, 1994) . These classifications/stages are based partly on symptom severity, and advanced stages were often a precursor to eligibility criteria for advanced heart failure research studies (Bekelman et al., 2009; Blinderman et al., 2008; Brannstrom & Boman, 2014; Janssen et al., 2011; Østergaard et al., 2018; Overbaugh & Parshall, 2016) . Although symptoms can occur across the disease trajectory, later staging is based on symptom severity and structural changes to the heart itself. New York Heart Association classifications have four classifications based on symptom severity and function, whereas American College of Cardiology/American Heart Association classifications focus on staging the structural and pathophysiological staging of the heart, with patients in Stage C and Stage D being likely to present with symptoms (Dolgin et al., 1994) . For patients to attribute their symptoms to heart failure, their diagnosis is important, and staging provides perspective of their condition and functional status, which is affected, in part, by symptoms.
Consequences. Consequences of symptom burden in heart failure included increased morbidity and mortality, decreased functioning, increased symptom prevalence and severity, decreased quality of life, and recurrent hospital admissions. High symptom burden (prevalence, severity, and frequency) was associated with increased morbidity and mortality rates for heart failure patients (Flint et al., 2017; Janssen et al., 2011) . In addition, the more comorbidities and symptoms a person with heart failure had, the more likely it was for the person to experience decreased functional status including diminished independence and activities of daily living (Evangelista et al., 2012; Flint et al., 2017; Gusick, 2008; Janssen et al., 2011) . As heart failure progresses, it leads to increased symptom prevalence and/or severity, which, in turn, had a negative effect on patients' quality of life (Blinderman et al., 2008; Evangelista et al., 2012; Lem & Schwartz, 2014; Zambroski et al., 2005) . Recurrent hospital admissions were also a common consequence of heavy symptom burden as individuals often sought health care for heart failure decompensation and other consequences associated with incremental disease-related burden (Blinderman et al., 2008; Brannstrom & Boman, 2014; Moser et al., 2005) .
Exemplar
No exemplar inclusive of all the above listed attributes was found in the literature. One reason might be the focus on one symptom or on individual symptom associations and outcomes in this population. Specific populations in which heart failure has a higher prevalence is known, for example, in older patients and in African American men (Benjamin et al., 2017) . To compare and distinguish low symptom burden with a higher, debilitating symptom burden, the following constructed exemplar is provided along with a proposed definition of symptom burden in heart failure (Tables 3 and 4) . Table 3 . Symptom Burden Exemplar. Exemplar Mrs. A, a woman in her mid-sixties, was diagnosed with heart failure two years ago.
Since then she had taken all of her medications as prescribed. She experiences many symptoms including dyspnea, and fatigue. However, she does not feel that her symptoms were terribly debilitating. She described her daily life as a "homebody" and her husband, now retired, assisted her with her daily tasks and in taking care of the house. Ms. J on the other hand is widowed and before her diagnosis three years ago was very active. She experiences the same symptoms as Mrs. A, however her symptoms keep her from the active lifestyle she once loved. She has a hard time keeping up with her multiple medications and since she has no family to assist her, her self-care and symptom management practices often do not follow the doctors' recommendations. She notices that whenever her edema worsens, she will have additional difficulty in catching her breath. She has experienced two hospital admissions in the past six months due to this and feels both isolated and hopeless due to the experience with her diagnosis. Whereas Mrs. A might not consider her symptom burden as "burdensome", Ms. J has a high symptom burden. As demonstrated through this exemplar, even though two people may have the similar heart failure symptoms, their experience of symptom burden can be very different.
Discussion
In this review, there was a lack of consensus on how to measure symptom burden in the heart failure population; researchers used instruments that were and were not heart failure specific. A future step to increasing study rigor is to ensure that symptom burden is measured consistently with a common measure that has been validated in the heart failure population (Corwin et al., 2014) . Although utilized symptom burden instruments such as the Edmonton Symptom Assessment Scale include multiple symptoms affiliated with other conditions, other instruments such as the Kansas City Cardiomyopathy Questionnaire and its Symptom Subscale are focused exclusively on symptoms in the context of heart failure (Bruera, Kuehn, Miller, Selmser, & Macmillan, 1991; Zambroski et al., 2004) . The utilization of instruments with different emphasis may indicate a conceptual difference between the measure of total symptom burden and a measure of what the researcher and clinician views as priority in symptom burden in heart failure. Psychological symptoms such as depression and anxiety are common in heart failure and fit within the symptom burden definition, they were not generally incorporated into symptom burden instruments. Instead, some studies used additional instruments such as the Hospital and Anxiety Depression Scale and the Patient Health Questionnaire-9 to assess mood and depression (Bekelman et al., 2018; Bekelman et al., 2009; Evangelista et al., 2012; Gerhardt et al., 2014; Gusick, 2008; Østergaard et al., 2018) . Based on these observations, it is hypothesized that future implications related to the development of the concept of symptom burden will focus on understanding the admissions Definition A proposed definition of symptom burden in heart failure is the total subjective experience (including symptom prevalence, frequency and severity) of heart failure symptom(s) that produce a negative impact on the patient or the patient's family and is a fluid phenomenon which can be measured over the course of their disease.
multidimensionality of symptoms, their impact on each other, and efforts to identify common measures for symptom burden, so that future research results are easier to interpret across studies. In addition, there is an increasing focus of the effect of palliative care on symptom burden in patients living with heart failure; 10 of the 20 articles in this review identified the benefits of palliative care (Bekelman et al., 2018; Bekelman et al., 2007; Blinderman et al., 2008; Brännström & Boman, 2014; Evangelista et al., 2014; Evangelista et al., 2012; Flint et al., 2017; Gandesbery et al., 2018; Janssen et al., 2011; Lem & Schwartz, 2014) . Concurrent palliative care has been to help reduce symptom burden in this population and improve quality of life, and this is recognized in the included literature; however, palliative care is still underutilized in this population (Hupcey, 2012; Kavalieratos et al., 2017; Yancy et al., 2013) . In conjunction with the cardiology team, palliative care can help heart failure patients and clinicians address unrelieved symptoms and other issues influencing health related quality of life. In addition, the interdisciplinary approach utilizing both the palliative team in treatment and management of heart failure aids in the introduction of advanced care planning preferences earlier in the disease trajectory (Yancy et al., 2013) . There are a growing number of studies highlighting the established benefits of palliative care for heart failure patients and its impact on symptom burden, especially with the growing number of chronic heart failure patients discharged from the hospital (Bakitas et al., 2017; Rogers et al., 2017; Willems, Hak, Visser, Cornel, & van der Wal, 2006) . Best practices for palliative care integration aiming to alleviate symptom burden and measure symptom burden in heart failure concurrent to standard medical treatment have not been fully explored (Barrett, 2017; Kavalieratos et al., 2017) .
In this literature search, four databases were used: PubMed, CINAHL, Embase, and Scopus. For a more comprehensive examination of the concept, further search into the gray literature may be helpful. Because this search was limited to the symptom burden of heart failure in a chronic outpatient or ambulatory population, a separate analysis focused on the inpatient setting may be helpful. As technology advances and more people are living with chronic heart failure and multiple symptoms, the concept of symptom burden will evolve to be reflective of this increasing number of people and their multiple comorbidities, and continuous adjustment of our understanding is needed.
The concept of symptom burden in heart failure lacks a current, clear definition and a gold standard for measure. Due to the unpredictable disease trajectory of heart failure, symptom burden is a fluid concept that can change with the patient's health state. Although the characteristics and attributes may be the same in the inpatient and outpatient populations for this concept, the importance and ramifications of these aspects are different, and treatment modalities may vary as well and warrant separate examination. Hence, this concept analysis highlights aspects of the concept of symptom burden seen in chronic heart failure that lack clarification and need better consensus for the clarity of future research. Symptom burden is a subjective experience that is most accurately reported by the patient. Those with chronic heart failure in the outpatient setting may experience their overall symptom burden differently than in the hospital setting due to both symptom prevalence and severity in addition to situational factors. Palliative care is important to the care of chronic heart failure outside of the hospital, and their emphasis-although reflected in current literature-needs further development to better understand their impact on these patients' symptom burden. In both settings, there is a lack of consensus on how to measure the concept and what constitutes symptom burden in heart failure. Further clarification is needed if research findings and clinical outcomes are to be compared.
